Jaguar Health, Inc. (JAGX) financial statements (2022 and earlier)

Company profile

Business Address 200 PINE STREET SUITE 400
SAN FRANCISCO, CA 94104
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 8,0903,4952,5685219517,698
Cash and cash equivalents 8,0903,4952,5685219517,698
Restricted cash and investments  388 239511 
Receivables2,1444,5601,6951,00246930559
Inventory, net of allowances, customer advances and progress billings4,9002,7822,1293,3422,073413230
Inventory4,9002,7822,1293,3422,073413230
Prepaid expense     303324
Deferred costs13    73143
Other undisclosed current assets21,3772,3601,8161,238497  
Total current assets:28,43417,7929,5228,1503,7992,5558,454
Noncurrent Assets
Operating lease, right-of-use asset1,084  
Property, plant and equipment6506777107611,222886829
Intangible assets, net (including goodwill)22,65124,33726,02431,71138,608  
Goodwill    5,211  
Intangible assets, net (excluding goodwill)22,65124,33726,02431,71133,397  
Restricted cash and investments      3,000
Other undisclosed noncurrent assets44637154421 122122
Total noncurrent assets:24,83125,05126,88832,89239,8301,0083,951
TOTAL ASSETS:53,26542,84336,41041,04243,6293,56312,405
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,0469,2528,27410,3549,5541,1001,373
Accounts payable4,9294,7595,3525,4147,355517574
Accrued liabilities7,1174,4932,9224,9392,200583798
Debt3,1843,7897,1154,8461,6091,9201,708
Deferred compensation liability    112  
Deferred revenue and credits5224252
Other undisclosed current liabilities241179311,4604,106949575
Total current liabilities:15,47113,22015,39226,65915,3864,1933,908
Noncurrent Liabilities
Long-term debt and lease obligation25,94112,421450 10,9821,8184,095
Long-term debt, excluding current maturities25,02212,421450 10,9821,8184,095
Operating lease, liability919  
Liabilities, other than long-term debt     73
Deferred revenue and credits 73
Other undisclosed noncurrent liabilities(919)      
Total noncurrent liabilities:25,94112,421450 10,9821,8244,098
Total liabilities:41,41225,64115,84226,65926,3686,0178,006
Temporary equity, carrying amount   9,000   
Stockholders' equity
Stockholders' equity attributable to parent, including:11,60717,20210,6745,38317,261(2,454)4,399
Common stock     11
Additional paid in capital231,100184,090142,04699,92779,65537,98130,101
Accumulated deficit(219,494)(166,899)(133,090)(94,551)(62,405)(40,436)(25,702)
Warrants and rights outstanding1 3    
Other undisclosed stockholders' equity attributable to parent 111,714611  
Stockholders' equity attributable to noncontrolling interest242      
Other undisclosed stockholders' equity4 9,894    
Total stockholders' equity:11,85317,20220,5685,38317,261(2,454)4,399
TOTAL LIABILITIES AND EQUITY:53,26542,84336,41041,04243,6293,56312,405

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 9,3855,7754,4164,361142258
Revenue, net1,485142258
Cost of revenue(2,333)(3,280)(3,816)(2,766)(880)(52)(123)
Gross profit:(2,333)6,1051,9591,6503,48190135
Operating expenses(41,076)(27,409)(30,259)(35,240)(38,608)(13,728)(12,704)
Other undisclosed operating income (loss)2,701(5,343)(649)2,76688052123
Operating loss:(40,708)(26,647)(28,948)(30,824)(34,247)(13,586)(12,445)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(765)1908131689(11)(27)
Interest and debt expense(9,174)(4,656)(10,672)(3,173)(1,687)(1,094)(3,317)
Loss from continuing operations before equity method investments, income taxes:(50,647)(31,113)(39,539)(33,681)(35,845)(14,691)(15,790)
Other undisclosed income (loss) from continuing operations before income taxes(1,953)(2,696)1,0091,535695  
Loss from continuing operations before income taxes:(52,600)(33,809)(38,529)(32,146)(35,150)(14,691)(15,790)
Income tax expense (benefit)  (10) 13,181(5,637)(4,785)
Loss before gain (loss) on sale of properties:(52,600)(33,809)(38,539)(32,146)(21,969)(20,327)(20,575)
Other undisclosed net income     5,5934,283
Net loss:(52,600)(33,809)(38,539)(32,146)(21,969)(14,734)(16,292)
Net income attributable to noncontrolling interest5      
Net loss attributable to parent:(52,595)(33,809)(38,539)(32,146)(21,969)(14,734)(16,292)
Preferred stock dividends and other adjustments   (995)  (346)
Other undisclosed net income available to common stockholders, basic   995   
Net loss available to common stockholders, diluted:(52,595)(33,809)(38,539)(32,146)(21,969)(14,734)(16,638)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(52,600)(33,809)(38,539)(32,146)(21,969)(14,734)(16,292)
Comprehensive loss:(52,600)(33,809)(38,539)(32,146)(21,969)(14,734)(16,292)
Comprehensive income, net of tax, attributable to noncontrolling interest5      
Comprehensive loss, net of tax, attributable to parent:(52,595)(33,809)(38,539)(32,146)(21,969)(14,734)(16,292)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: